166 related articles for article (PubMed ID: 35409724)
21. The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.
Chodick G; Tene L; Rotem RS; Patalon T; Gazit S; Ben-Tov A; Weil C; Goldshtein I; Twig G; Cohen D; Muhsen K
Clin Infect Dis; 2022 Feb; 74(3):472-478. PubMed ID: 33999127
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
Fowlkes AL; Yoon SK; Lutrick K; Gwynn L; Burns J; Grant L; Phillips AL; Ellingson K; Ferraris MV; LeClair LB; Mathenge C; Yoo YM; Thiese MS; Gerald LB; Solle NS; Jeddy Z; Odame-Bamfo L; Mak J; Hegmann KT; Gerald JK; Ochoa JS; Berry M; Rose S; Lamberte JM; Madhivanan P; Pubillones FA; Rai RP; Dunnigan K; Jones JT; Krupp K; Edwards LJ; Bedrick EJ; Sokol BE; Lowe A; McLeland-Wieser H; Jovel KS; Fleary DE; Khan SM; Poe B; Hollister J; Lopez J; Rivers P; Beitel S; Tyner HL; Naleway AL; Olsho LEW; Caban-Martinez AJ; Burgess JL; Thompson MG; Gaglani M
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(11):422-428. PubMed ID: 35298453
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.
Lim AH; Ab Rahman N; Ong SM; Paraja J; Rashid R; Parmar IS; Dahlan SN; Tan ZSS; Bohari I; Peariasamy KM; Sivasampu S
Vaccine; 2022 Sep; 40(39):5675-5682. PubMed ID: 36030123
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccine uptake and effectiveness in adults aged 50 years and older in Wales UK: a 1.2m population data-linkage cohort approach.
Perry M; Gravenor MB; Cottrell S; Bedston S; Roberts R; Williams C; Salmon J; Lyons J; Akbari A; Lyons RA; Torabi F; Griffiths LJ
Hum Vaccin Immunother; 2022 Dec; 18(1):2031774. PubMed ID: 35239462
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.
Glatman-Freedman A; Bromberg M; Hershkovitz Y; Sefty H; Kaufman Z; Dichtiar R; Keinan-Boker L
Emerg Infect Dis; 2022 May; 28(5):948-956. PubMed ID: 35361311
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain).
Chico-Sánchez P; Gras-Valentí P; Algado-Sellés N; Jiménez-Sepúlveda N; Vanaclocha H; Peiró S; Burgos JS; Berenguer A; Navarro D; Sánchez-Payá J;
Prev Med; 2022 Oct; 163():107237. PubMed ID: 36057393
[TBL] [Abstract][Full Text] [Related]
27. The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac.
Tonnara G; Piselli P; Cimaglia C; Arlotti M; Sacchini E; Manoni S; Zani A; Muccioli F; Laderchi A; Rabini S; Antinori A; Vaia F; Nicastri E; Girardi E
Clin Microbiol Infect; 2022 Dec; 28(12):1636-1643. PubMed ID: 35798146
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of the first dose of BNT162b2 vaccine to preventing covid-19 in healthcare personnel.].
Gras-Valentí P; Chico-Sánchez P; Algado-Sellés N; Jiménez-Sepúlveda NJ; Gómez-Sotero IL; Fuster-Pérez M; Cartagena-Llopis L; Sánchez-Valero M; Cerezo-Milán P; Martínez-Tornero I; Tremiño-Sánchez L; Nadal-Morante V; Monerris-Palmer M; Esclapez-Martínez A; MorenodeArcos-Fuentes E; Escalada-Martín I; Escribano-Cañadas I; Merino-Lucas E; Rodríguez-Díaz JC; Sánchez-Payá J
Rev Esp Salud Publica; 2021 Apr; 95():. PubMed ID: 33913444
[TBL] [Abstract][Full Text] [Related]
29. Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
Lutrick K; Rivers P; Yoo YM; Grant L; Hollister J; Jovel K; Khan S; Lowe A; Baccam Z; Hanson H; Olsho LEW; Fowlkes A; Caban-Martinez AJ; Porter C; Yoon S; Meece J; Gaglani M; Burns J; Mayo Lamberte J; Nakayima Miiro F; Bissonnette A; LeClair L; Kutty PK; Romine JK; Stefanski E; Edwards LJ; Ellingson K; Gerald JK; Bedrick EJ; Madhivanan P; Krupp K; Gerald LB; Thompson M; Burgess JL
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1761-1765. PubMed ID: 34968373
[TBL] [Abstract][Full Text] [Related]
30. Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study.
Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Cohen AD
Am J Clin Dermatol; 2022 May; 23(3):385-392. PubMed ID: 35294720
[TBL] [Abstract][Full Text] [Related]
31. Vaccine Effectiveness, School Reopening, and Risk of Omicron Infection Among Adolescents Aged 12-17 Years.
Risk M; Miao H; Freed G; Shen C
J Adolesc Health; 2023 Jan; 72(1):147-152. PubMed ID: 36216679
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine.
Saciuk Y; Kertes J; Shamir Stein N; Ekka Zohar A
J Infect Dis; 2022 Jan; 225(1):30-33. PubMed ID: 34726239
[TBL] [Abstract][Full Text] [Related]
33. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.
Pawlowski C; Lenehan P; Puranik A; Agarwal V; Venkatakrishnan AJ; Niesen MJM; O'Horo JC; Virk A; Swift MD; Badley AD; Halamka J; Soundararajan V
Med; 2021 Aug; 2(8):979-992.e8. PubMed ID: 34223401
[TBL] [Abstract][Full Text] [Related]
34. Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study.
Barchuk A; Cherkashin M; Bulina A; Berezina N; Rakova T; Kuplevatskaya D; Stanevich O; Skougarevskiy D; Okhotin A
BMC Med; 2022 Sep; 20(1):312. PubMed ID: 36123681
[TBL] [Abstract][Full Text] [Related]
35. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
Tang P; Hasan MR; Chemaitelly H; Yassine HM; Benslimane FM; Al Khatib HA; AlMukdad S; Coyle P; Ayoub HH; Al Kanaani Z; Al Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Nasrallah GK; Al Kuwari MG; Al Romaihi HE; Butt AA; Al-Thani MH; Al Khal A; Bertollini R; Abu-Raddad LJ
Nat Med; 2021 Dec; 27(12):2136-2143. PubMed ID: 34728831
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January-May 2021, Aragon, Spain.
Del Cura-Bilbao A; López-Mendoza H; Chaure-Pardos A; Vergara-Ugarriza A; Guimbao-Bescós J
Emerg Infect Dis; 2022 Mar; 28(3):591-598. PubMed ID: 35195514
[TBL] [Abstract][Full Text] [Related]
37. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
[TBL] [Abstract][Full Text] [Related]
38. Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Turbyfill C; Adams K; Tenforde MW; Murray NL; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Clark Files D; Hager DN; Shehu A; Prekker ME; Frosch AE; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Lauring AS; Khan A; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; June Gordon A; Qadir N; Chang SY; Mallow C; Rivas C; Kwon JH; Halasa N; Chappell JD; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Rhoads JP; Lindsell CJ; Hart KW; McMorrow M; Surie D; Self WH; Patel MM
Vaccine; 2022 Nov; 40(48):6979-6986. PubMed ID: 36374708
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]